Researchers identified several socioeconomic and logistic barriers that limit diversity in clinical trials.
Disparities in Blood Cancers
Advertisement
This research promotes progress in understanding how tumor genetics differs across individuals of different ancestry.
A drug used to treat some types of leukemia may offer patients with refractory multiple myeloma a new avenue for treatment.
Restrictive trial eligibility criteria and geographic limitations likely contribute to these disparities.
Little is known about the effect of recent advances, particularly the approval of venetoclax, in acute myeloid leukemia.
Researchers investigated whether socioeconomic status and healthcare resource availability affect OS in multiple myeloma.
Persistent or newly developed lymphopenia after diagnosis was also linked to an increased risk of mortality.
Individuals living in lower-income areas experience disproportionately higher rates of late-stage diagnoses and mortality.
responding physicians (92%) reported that prior authorization causes treatment delays for their patients
Expert Interviews
Urban Health Today reports on clinical news and policy updates that directly impact urban health care providers and their patients.
Get research and expert insights straight to your inbox.
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.